Harrow Health to Participate in H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference

NASHVILLE, Tenn.--(BUSINESS WIRE)---- $HROW--Harrow Health, Inc. (Nasdaq: HROW), an eyecare pharmaceutical company focused on the development, production, sale, and distribution of innovative ophthalmic prescription medicines, today announced that Mark L. Baum, Chief Executive Officer, and Andrew Boll, Chief Financial Officer, will participate in the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference to be held on August 17, 2022. Harrow Health’s pre-recorded presentation will be available via a